New agile solutions to accelerate digital supply chain transformation
New solutions will provide critical transparency to the life sciences supply chain, mobilizing companies to rapidly react to unforeseen disruptions and ensure medicine supply.
TraceLink, a leading digital platform company for the life sciences industry, has announced a new package of agile solutions designed to digitalize the pharmaceutical supply chain.
In response to COVID-19, TraceLink has "urgently" prioritized its focus on delivering solutions that will have an immediate impact in helping companies to meet unforeseen supply chain challenges and ensure the safe delivery of critical medicines and supplies to their patients.
Available on TraceLink’s Opus platform, the new agile solutions tap into TraceLink’s end-to-end network connectivity, data sharing, and multi-party process orchestration, giving companies the visibility and responsiveness needed for their supply chains to thrive in today’s challenging environment.
The centralized network-based system identifies, tracks and resolves supply partner issues in real-time. Agile Issue Management connects internal teams with external suppliers and downstream customers to manage unforeseen supply chain disruptions and resolve them faster.
When supply and demand experience massive fluctuation, drug shortages are inevitable. By leveraging the power of TraceLink’s network data and advanced analytics, TraceLink’s Drug Shortage Intelligence solution provides network-wide insights into supply and patient demand, allowing customers to accurately predict and prevent drug shortages, ensuring critical medicines are available to every patient.
By integrating Internet of Things with product serialization, this solution will provide full track and trace visibility for the secure delivery of vaccines, test kits and high-value products.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance